If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elena Fumagalli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Gastrointestinal Stromal Tumors Medicine & Life Sciences
Motor Neurons Medicine & Life Sciences
Mutation Medicine & Life Sciences
Glutamic Acid Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 2012 Citations
  • 25 h-Index
  • 64 Article
1 Citation (Scopus)

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST

Urbini, M., Indio, V., Tarantino, G., Ravegnini, G., Angelini, S., Nannini, M., Saponara, M., Santini, D., Ceccarelli, C., Fiorentino, M., Vincenzi, B., Fumagalli, E., Casali, P. G., Grignani, G., Pession, A., Ardizzoni, A., Astolfi, A. & Pantaleo, M. A., Sep 2019, In : Genes Chromosomes and Cancer. 58, 9, p. 636-642 7 p.

Research output: Contribution to journalArticle

Open Access
Gastrointestinal Stromal Tumors
Fibroblast Growth Factor Receptors
Intercellular Signaling Peptides and Proteins
Messenger RNA

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response

Pantaleo, M. A., Tarantino, G., Agostinelli, C., Urbini, M., Nannini, M., Saponara, M., Castelli, C., Stacchiotti, S., Fumagalli, E., Gatto, L., Santini, D., De Leo, A., Marafioti, T., Akarca, A., Sabattini, E., Pession, A., Ardizzoni, A., Indio, V. & Astolfi, A., Sep 2 2019, In : OncoImmunology. 8, 9, e1617588.

Research output: Contribution to journalArticle

Open Access
Gastrointestinal Stromal Tumors
Gene Expression
Tumor Microenvironment
Gastrointestinal Stromal Tumors
Protein-Tyrosine Kinases

Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas)

Sanfilippo, R., Jones, R. L., Blay, J. Y., Cesne, A. L., Provenzano, S., Antoniou, G., Mir, O., Fucà, G., Fumagalli, E., Bertulli, R., Stacchiotti, S., Brahmi, M., Grosso, F., Dufresne, A., Hindi, N., Sbaraglia, M., Gronchi, A., Collini, P., Dei Tos, A. P. & Casali, P. G., Sep 1 2019, In : Clinical Cancer Research. 25, 17, p. 5295-5300 6 p.

Research output: Contribution to journalArticle

Perivascular Epithelioid Cell Neoplasms
Disease-Free Survival
Drug Therapy

Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting

Reichardt, P., Schlemmer, M., Delgado Perez, J. R., Papai, Z., Prausova, J., Melichar, B., Fumagalli, E., Barone, C., Bauer, S., Pustowka, A., Crippa, S., Castellana, R., Quiering, C. & Le Cesne, A., Jan 1 2019, (Accepted/In press) In : Oncology Research and Treatment.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Genetic Therapy